Get a Roundup of Psychedelic News Stories in Your Inbox.

    By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

    Psychedelic Business News Spotlight: December 10, 2020

    This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.

    Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics

    Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.
    Psychedelic Business News Spotlight
    Peter Thiel Invests $12 Million In Psychedelic Drug Manufacturer
    Publicly-Traded Psychedelic Stocks
    Psychedelic Tech Company Cybin Brings In a $45 Million
    Dr. Andrew Weil Joins Advisory Board for Psychedelic Therapy Platform
    Field Trip Is the Latest Psychedelic Therapy Company to Go Public
    Ibogaine and LSD Producer MindMed Applies for Nasdaq Up-Listing
    Compass Pathways IPO Brings $1 Billion Valuation
    Investors Are Betting On Psychedelics
    The Psychedelic Medicine Association
    Quick-Dissolve Strips to Psychedelics
    CEO of Canadian Stock Exchange on Psychedelic Investments
    Canadian Manufacturer Licensed to Make Psilocybin
    Low Doses of LSD Make Opioids Obsolete
    Quest For A Market-Friendly Synthetic Psilocybin
    © 2020 Psychedelic Spotlight. All rights reserved. Owned and operated by Global Trac Solutions, Inc. a US publicly traded company (OTCPink: PSYC)
    Web Design & SEO by SunCity Advising | All Rights Reserved.